Logo Brain & MindBrain & Mind
Brain & Mind

The Greater Paris Neuroscience Cluster

scroll down

Context

Diseases of the brain are devastating and growing at a fast rate

Neurology • Psychiatry • Sensory disorders

1st direct and indirect healthcare cost in the world

850 B€of yearly annual cost in Europe 1st cause of healthy life year loss in the world 1st cause of invalidity in the world
60%of yearly annual cost in Europe 1st perceived threat to individual dignity in the population 60% more medication for mental health in the past 10 years

Context

Mental health needs are on the rise

Evolution of anxiety, depression and suicidal thoughts before and after the COVID epidemic
Internet search for mental health services

Context

With recent methodological breakthroughs in research a new industry ecosystem is growing and investments are on the rise

Braintech VC funding (USA)

Evolution Braintech VC funding in USA

Braintech VC funding (EU)

Evolution Braintech VC funding in EU

Founders & Partners

Major research Institutes in Paris region such as Paris Brain Institute, FondaMental foundation, Vision Institute have initiated a translational research engine supporting innovation and industry growth

Major Hospitals and clinical networks

+100,000 individual patients/year
  • Experienced clinical Research Centers
  • +20 National Rare Disease Reference Centers
  • + 100,000 new patients/year
  • Multimodal biomarkers

Technology acceleration units

+80 start-ups | +300 industry partners
  • Homelab
  • Hospital living lab
  • Fast prototyping
  • 4 dedicated bioincubators within 500m radius

Translational research Institutes

+1,000 research personnels
  • Developmental Biology
  • Genetics/Genomics
  • Physiology/Restoration ; Robotics, Maths
  • Photonics
  • Pathophysiology/Therapeutics

Founders & Partners

Paris Brain Institute
Institut de la Vision
Fondation FondaMental
UCB
Inserm
APHP
Medicen
Ville de Paris
Unafam
Health Data Hub
Malakoff Humanis
Sorbonne Université
Université Paris Cité
GHU Paris psychiatrie & neurosciences
Région Île-de-France
EIT Health
France Biotech
Institut de l'Audition
Institut Robert-Debré du cerveau de l'enfant
Ideal
Biogen
Snitem
Université Paris-Est Créteil
Leem
NeuroSpin
Institut Imagine
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Hôpital Fondation Adolphe de Rothschild
Cognition and Brain Revolutions Artificial Intelligence, Neurogenomics and Society
GenSight Biologics
Roche
Novartis
Bayer
AskBio
Sofinnova Partners
SparingVision
Siemens Healthineers
Newfund
BioSerenity
Dassault Systèmes
Edmond de Rothschild
Humans Matter
Discovery Ventures

Objectives

To transform the Neuroscience ecosystem, Brain&Mind will invest in three major areas

Early derisking of neuroscience technologiesThe early derisking of neuroscience technologies (biotech, medtech, prevention)
  • VC-coached data-package building
  • Entrepreneurial launchpad
  • Scientific evidence reinforcemen
Development of innovative productsSuccessful clinical development of innovative products
  • Scale-up of multimodal biomarkers
  • New clinical methododologies and RWE
  • Cooperative research infrastructure
Training of SpecialistsTraining of the next generation of engineers, entrepreneurs, caregivers
  • Living lab approaches
  • Cross-sectorial trainings
  • Policy lab

Now is the right time!

France 2030